What are the side effects and safety considerations of Zoloft (sertraline)?

Zoloft (Sertraline) Side Effects and Safety Profile

Sertraline causes common gastrointestinal side effects—particularly diarrhea, nausea, and vomiting—along with sexual dysfunction, but is generally well-tolerated with a favorable safety profile compared to older antidepressants. 1

Common Side Effects

The most frequently reported adverse events with sertraline include: 1

• Gastrointestinal effects: Nausea, diarrhea/loose stools, loss of appetite, indigestion
• Neurological effects: Headache, dizziness, tremor/shaking, insomnia or increased sleepiness
• Other effects: Increased sweating, fatigue, sexual dysfunction (decreased libido, ejaculatory disturbance)

Sertraline specifically has a higher rate of diarrhea compared to other SSRIs including bupropion, citalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, and venlafaxine. 1

Nausea and vomiting are the most common reasons patients discontinue sertraline. 1

Timing and Management of GI Effects

• Most gastrointestinal side effects emerge within the first few weeks of treatment and are typically mild and transient, decreasing with continued use. 2, 3
• Starting with lower doses (25-50 mg daily) can reduce the incidence of gastrointestinal side effects. 2
• Taking sertraline with food may help reduce nausea. 2

Serious Adverse Effects Requiring Monitoring

Sexual Dysfunction

• Sexual side effects occur in approximately 40% of patients on SSRIs (weighted mean across observational studies). 1
• Effects typically begin within the first week of treatment. 1
• Sertraline has lower rates of sexual dysfunction compared to paroxetine but higher rates than bupropion. 1

Suicidality Risk

SSRIs including sertraline are associated with an increased risk of nonfatal suicide attempts (odds ratio 1.57-2.25), though not completed suicide. 1

• Risk is age-dependent: slightly increased in adults 18-24 years (OR 2.30), neutral for ages 25-64, and protective in those ≥65 years (OR 0.06). 1
• Highest risk occurs within 1-2 months of initiation or dose increase. 1

Serotonin Syndrome

Serotonin syndrome occurs in 14-16% of SSRI overdoses and can develop within 24-48 hours when combining serotonergic medications or increasing doses. 1, 2, 4

Critical warning signs include: 2, 4

• Mental status changes (agitation, confusion)
• Autonomic instability (tachycardia, labile blood pressure, hyperthermia)
• Neuromuscular symptoms (tremor, rigidity, myoclonus, hyperreflexia, uncontrolled muscle spasms)
• Gastrointestinal symptoms (nausea, vomiting, diarrhea)

Other Serious Adverse Effects

• Hyponatremia: Occurs in 0.5-12% of older adults, typically within the first month (OR 3.3 for SSRIs vs. other drug classes). 1
• Gastrointestinal bleeding: Increased risk (OR 1.2-1.5), higher with concurrent NSAIDs or antiplatelet drugs. 1
• QT prolongation: Less concern with sertraline compared to citalopram or escitalopram. 1
• Hepatotoxicity: Lower risk with SSRIs compared to TCAs; typically occurs within 6 months if it develops. 1

Special Populations

Pregnancy and Breastfeeding

• Sertraline and paroxetine are the most commonly prescribed antidepressants during breastfeeding. 1
• Sertraline transfers in lower concentrations into breast milk and produces undetectable infant plasma levels. 1
• Limited evidence suggests potential associations with lower Apgar scores, ADHD, and speech delay, though high-quality evidence is lacking. 1

Elderly Patients (≥60 years)

• Sertraline is a preferred agent for older adults with depression due to minimal anticholinergic effects and low drug interaction potential. 1, 5
• No dosage adjustment needed based on age alone. 5
• Tolerability profile is similar between younger and elderly patients. 5

Pediatric Patients

Additional side effects in children and adolescents include: 4

• Abnormal increase in muscle movement or agitation
• Nosebleed, urinary frequency, urinary incontinence
• Aggressive reactions, heavy menstrual periods
• Possible slowed growth rate and weight changes (requires monitoring)

Discontinuation Syndrome

Abrupt cessation of sertraline can cause withdrawal symptoms including dizziness, fatigue, headaches, nausea, vomiting, diarrhea, insomnia, anxiety, and irritability. 2

• Use a brief taper rather than abrupt cessation to minimize symptoms. 2
• Sertraline's 22-36 hour half-life makes discontinuation syndrome less severe than shorter-acting SSRIs. 6

Drug Interactions and Contraindications

Sertraline has minimal inhibitory effects on cytochrome P450 enzymes, resulting in fewer clinically significant drug interactions compared to other SSRIs. 6, 5

Critical interactions to avoid: 4

• MAO inhibitors (contraindicated)
• Other serotonergic medications (triptans, tramadol, St. John's Wort, tryptophan)
• Warfarin (increased bleeding risk)
• Antiarrhythmics (propafenone, flecainide)

Clinical Pearls

• About 63% of patients on second-generation antidepressants experience at least one adverse effect. 1
• Sertraline is essentially devoid of cardiovascular effects and has a wide therapeutic index, making it safe in patients with underlying cardiovascular disorders. 3
• In patients with irritable bowel syndrome, SSRIs including sertraline may worsen diarrhea-predominant symptoms by increasing gastric and intestinal motility. 2
• Steady-state plasma concentrations vary widely (up to 15-fold) at standard doses, but therapeutic drug monitoring is not routinely recommended. 6
• Sertraline is relatively safe in overdose compared to tricyclic antidepressants. 7, 6